What is the genMARK study?

Throughout the COVID-19 pandemic, a great variation in illness of individuals with COVID-19 has been noted. There are differences in both severity of the COVID-19 illness as well as the presentation of signs and symptoms. One reason for this variation could be our genetic differences that influence our body’s response to COVID-19 .

The genMARK study focuses on children and adults with a spectrum of COVID-related illnesses. Using genetic research, this study seeks to understand whether a person’s genetics affect the severity of their COVID-19 illness.

The genMARK study aims to find out why some individuals have severe forms of Coronavirus (COVID-19) illness, while others get mild illness, even when they are otherwise healthy.

Learn more

The genMARK study aims to find out why some individuals have severe forms of Coronavirus (COVID-19) illness, while others get mild illness, even when they are otherwise healthy.

Learn more about the study

Study steering committee

The genMARK steering committee is made up of researchers who are most responsible for major decision-making for the research project. They work closely with other members of the research team, who collectively help to frame the conduct of the study, oversee deliverables and assist with knowledge translation.

Dr. Upton Allen's full profile

Dr. Upton Allen, SickKids

Dr. Shaun Morris' full profile

Dr. Shaun Morris, SickKids

Dr. Julia Upton, SickKids

Dr. Lisa Strug, SickKids

Dr. Jesse Papenburg's full profile

Dr. Jesse Papenburg, Montreal Children’s Hospital

Dr. Manish Sadarangani's full profile

Dr. Manish Sadarangani, BC Children’s Hospital

Tex Kissoon's full profile

Dr. Tex Kissoon, BC Children’s Hospital

Not pictured:

Dr. Allison McGeer, Mount Sinai Hospital

Collaborator Hub

A centralized space for all collaborators to access resources related to the coordination of the genMARK study. Password required.

Enter the collaborator hub